September 25, 2013 — Sensus Healthcare announced its newest introduction for non-melanoma skin cancer treatment at the 55th annual American Society of Therapeutic Radiation Oncology (ASTRO) in Atlanta, Ga. Sensus has an advanced SRT-100 superficial radiotherapy platform, featuring SharpBeam and has introduced the recently FDA-cleared technology that now allows you to "See what you Treat."
The SRT-100 "Vision" offers unique features and benefits providing major teaching and community hospitals with a cost effective, proven, noninvasive option for treating their patients who are diagnosed with skin cancer.
For more information: www.sensushealthcare.com
April 10, 2026 
